Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 3-butylidene-1(3H)-isobenzofuranone
- Correlated keywords
- NSC325307 BFTC905 SCA-3 Ligusticum Lasioderma butylidene phthalide
- Product Overview:
3-Butylidenephthalide is a plant metabolite that has been found in L. jeholense and has diverse biological activities.{62715,62716,62717,62714} 3-Butylidenephthalide (60 µg/ml) induces apoptosis and inhibits migration and the epithelial-to-mesenchymal transition (EMT) in 5637, BFTC-905, T24, and TCCSUP human bladder cancer cells.{62715} In vivo, 3-butylidenephthalide (100 and 200 mg/kg) reduces tumor volume in a BFTC-905 mouse xenograft model. 3-Butylidenephthalide (400 mg/kg) increases life span and reduces spinal motor neuron loss in an SOD1G93A mouse model of amyotrophic lateral sclerosis (ALS).{62716} It also reduces undegradable polyglutamine (polyQ) accumulation and cerebral atrophy, as well as improves motor coordination in a mouse model of spinocerebellar ataxia type 3 (SCA3), effects that can be reversed by the autophagy inhibitors bafilomycin A1 (Item No. 11038) and wortmannin (Item No. 10010591).{62717} It is toxic to adult tobacco beetles (L. serricorne; LD50 = 13.64 µg/insect).{62714}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.